Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Phase II Study to Evaluate the Efficacy and Safety of Oral Ceritinib in Patients With ALK-positive NSCLC Metastatic to the Brain and/or to Leptomeninges

Novartis Pharmaceuticals · 2015
ClinicalTrials.gov · Datasets · License: Public Domain · 2015
Open Source ↗
non-small-cell-lung-cancernsclc
alk-positive non-small cell lung cancer, alk-positive, nsclc, non-small cell lung cancer, brain metastasis, metastatic to the brain and/or to leptomeninges, ceritinib, ldk378, nsclc metastatic to the brain, leptomeninges harboring a confirmed alk rearrangement, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 839156
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.